Narrow-spectrum drug repurposing: targeting Gardnerella vaginalis biofilms associated with bacterial vaginosis | Synapse
March 3, 2026Open Access
Narrow-spectrum drug repurposing: targeting Gardnerella vaginalis biofilms associated with bacterial vaginosis
Key Points
MMV1582487 shows selective anti-biofilm activity against Gardnerella vaginalis, offering a promising treatment option.
In vitro tests indicate that MMV1582487 is non-cytotoxic, which is important for safety in therapy development.
The findings support exploring new therapeutic pathways to treat bacterial vaginosis more effectively.
Further research is needed to fully validate the efficacy of this anti-biofilm candidate in clinical applications.
Abstract
We demonstrate that MMV1582487 is a selective, non-cytotoxic, anti-biofilm candidate against G. vaginalis, supporting its potential as a novel therapeutic option for BV.